M Tanaka

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

Katsumasa Sato, Kazuki Hoshino, M Tanaka et al. · Antimicrobial Agents and Chemotherapy · 1992 · 123 citations

Life Sciences, Microbiology, Pharmacology +8

Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes

M Tanaka, Hisato Jingami, Haruhisa Otani et al. · Journal of Biological Chemistry · 1993 · 105 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Long-standing complications after treatment for cancer of the uterine cervix-clinical significance of medical examination at 5 years after treatment

Yutaka Matsuura, Toshinori Kawagoe, Naoyuki Toki et al. · International Journal of Gynecological Cancer · 2006 · 99 citations

Medicine, Oncology, Surgery +9

Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers

M Nakashima, Toshihiko Uematsu, Kazuhiro Kosuge et al. · Antimicrobial Agents and Chemotherapy · 1995 · 77 citations

Medicine, Pharmacokinetics, Pharmacology +9

Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus

M Tanaka, Yoshikuni Onodera, Y. Uchida et al. · Antimicrobial Agents and Chemotherapy · 1997 · 75 citations · Full text

Life Sciences, Microbiology, Pharmacology +15